Validation and Promise of a TCR Mimic Antibody for Cancer Immunotherapy of Hepatocellular Carcinoma

Investigators explored the specificity and safety profile of a new T cell receptor (TCR) mimic-based T cell therapy for hepatocellular carcinoma, a solid tumor for which no effective treatment exists.